Deltec Asset Management
PASG icon

Deltec Asset Management’s Passage Bio PASG Stock Holding History

Deltec Asset Management’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$67.5K Hold
15,000
– – 0.01% 243
2026
Q2 		$73.2K Buy
+15,000
New +$93.8K 0.01% 254

Other funds holding PASG

Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.16B AUM 31.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Erste Asset Management
Erste Asset Management Vienna, Austria $13.7B AUM 40.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
HRT Financial
HRT Financial New York $57.2B AUM 52.85% 1-Year Est. Return

Deltec Asset Management's PASG Position: Q3 2026 in Review

Deltec Asset Management held its Passage Bio (PASG) position steady in Q3 2026 at 15,000 shares worth $67.5K. The position accounts for 0.01% of the portfolio, ranked #243.

Deltec Asset Management first reported a position in PASG in Q2 2026 and has held it in 2 quarters since. The position peaked at $73.2K in Q2 2026. 20 funds tracked by Wall St. Rank hold PASG as of Q3 2026.

  • Deltec Asset Management held 15,000 shares of Passage Bio worth $67.5K as of Q3 2026.
  • Deltec Asset Management left its Passage Bio share count unchanged in Q3 2026.
  • Passage Bio made up 0.01% of Deltec Asset Management's portfolio in Q3 2026, its #243 holding.
  • Deltec Asset Management first reported a position in Passage Bio in Q2 2026 and has held it in 2 quarters since.
  • Deltec Asset Management's Passage Bio position peaked at $73.2K in Q2 2026.
  • 20 funds tracked by Wall St. Rank held Passage Bio as of Q3 2026.

Based on Deltec Asset Management's 13F filing for Q3 2026, filed 26 Oct 2026.